author-photo

Erica Nicola Lynch

University of Padua

6

Papers

16

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease

2021 European Journal of Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.

2021 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (2)